FDA And EMA Collaborate On Advice For Complex Generics And Hybrids

US-EU Pilot Program Will Provide Parallel Scientific Advice For Applicants

The US and EU agencies are working together on complex generics and hybrids • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Regulation

More from Policy & Regulation